alanine has been researched along with Action Tremor in 5 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Safinamide is an α-aminoamide derivative that is currently in Phase III clinical trial development as an add-on therapy to levodopa or dopamine agonists for patients with Parkinson's disease." | 5.39 | Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor. ( Collins-Praino, LE; Lobianco, C; Podurgiel, S; Randall, PA; Roach, A; Salamone, JD; Yohn, S, 2013) |
| " into male mice potentiated and prolonged the oxotremorine and physostigmine-induced tremor in a dose-dependent manner." | 3.67 | In vivo and in vitro studies on the potentiation of muscarinic receptor stimulation by alaproclate, a selective 5-HT uptake blocker. ( Bartfai, T; Danielsson, E; Nordström, O; Ogren, SO; Peterson, LL, 1985) |
| "The dose-effect of oxotremorine upon the onset, duration and magnitude of tremor and salivation was studied in both mice and rats." | 3.67 | Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse. ( Bartfai, T; Carlsson, S; Ogren, SO, 1985) |
| "Safinamide is an α-aminoamide derivative that is currently in Phase III clinical trial development as an add-on therapy to levodopa or dopamine agonists for patients with Parkinson's disease." | 1.39 | Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor. ( Collins-Praino, LE; Lobianco, C; Podurgiel, S; Randall, PA; Roach, A; Salamone, JD; Yohn, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Podurgiel, S | 1 |
| Collins-Praino, LE | 1 |
| Yohn, S | 1 |
| Randall, PA | 1 |
| Roach, A | 1 |
| Lobianco, C | 1 |
| Salamone, JD | 1 |
| Ogren, SO | 2 |
| Nordström, O | 1 |
| Danielsson, E | 1 |
| Peterson, LL | 1 |
| Bartfai, T | 2 |
| Rostain, JC | 1 |
| Wardley-Smith, B | 1 |
| Forni, C | 1 |
| Halsey, MJ | 1 |
| Carlsson, S | 1 |
| Burns, R | 1 |
| Thomas, DW | 1 |
| Barron, VJ | 1 |
5 other studies available for alanine and Action Tremor
| Article | Year |
|---|---|
Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
Topics: Alanine; Animals; Antiparkinson Agents; Benzylamines; Dopamine Agonists; Locomotion; Male; Muscarini | 2013 |
In vivo and in vitro studies on the potentiation of muscarinic receptor stimulation by alaproclate, a selective 5-HT uptake blocker.
Topics: Alanine; Animals; Brain; Cyclic GMP; Drug Synergism; Hippocampus; Male; Mice; Oxotremorine; Physosti | 1985 |
Gamma-aminobutyric acid and the high pressure neurological syndrome.
Topics: Alanine; Aminobutyrates; Animals; Atmospheric Pressure; Central Nervous System Diseases; Electrodes, | 1986 |
Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse.
Topics: Alanine; Animals; Arecoline; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred Strains; Oxo | 1985 |
Reversible encephalopathy possibly associated with bismuth subgallate ingestion.
Topics: Adult; Aged; Alanine; Arginine; Bismuth; Brain Diseases; Cerebellum; Chromatography; Cognition Disor | 1974 |